AI-09 In Subjects With Glabellar Lines, GL-101

Clinical trial NCT05565950 · COMPLETED

Trial details

NCT number: NCT05565950
Sponsor: Eirion Therapeutics Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Glabellar Frown Lines

Start date: 2022-09-03
Primary completion: 2024-06-03
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.